Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
13.39
USD
0.53%
Market Closed
Market Cap:
$2.1B
Relative Value
The Relative Value of one
ADPT
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 13.39 USD,
Adaptive Biotechnologies Corp
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ADPT Relative Value
HIDDEN
Multiples Across Competitors
ADPT Competitors Multiples
Adaptive Biotechnologies Corp Competitors
Adaptive Biotechnologies Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
2.1B USD | 7.7 | -36.1 | -52.5 | -36.1 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
979.9B USD | 343.1 | 4 062.5 | 1 164.1 | 2 241.6 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
177.8B USD | 4 | 26.5 | 18.5 | 24.9 | |
| US |
|
Danaher Corp
NYSE:DHR
|
138B USD | 5.6 | 38.2 | 19.4 | 28.2 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.1B CHF | 5.1 | 34.9 | 26.1 | 26.1 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
264.5B CNY | 6 | 17.6 | 17.7 | 17.7 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.9B USD | 4.5 | 24.7 | 18.2 | 21.5 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.1B USD | 9.2 | 45.3 | 29.3 | 36.8 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.6B USD | 1.8 | 21.1 | 11.8 | 17.7 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
24.6B USD | 6.1 | 28.3 | 21.1 | 23.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
